Crinetics Pharmaceuticals Inc (CRNX)
SG&A Expense Growth
13.26%
Quarterly · Period ending:
CRNX SG&A Expense Growth
Latest reported13.26%period ending
Latest reported13.26%period ending
CRNX Quarterly SG&A Growth (QoQ) (0.00% → 13.26%)
Latest values, visible window
High-resolution chart · PNG
CRNX sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 13.2636% | |
| -5.3391% | |
| 2.7418% | |
| 4.8614% | |
| 40.2972% | |
| 26.0726% | |
| 8.8328% | |
| 4.2435% | |
| 19.2529% | |
| 21.9581% | |
| 10.2945% | |
| 16.0459% | |
| 9.4676% | |
| 8.116% | |
| -5.4591% | |
| 13.6905% | |
| 20.4801% | |
| 18.2559% | |
| 18.2271% | |
| 11.1567% | |
| 5.0244% | |
| 7.5186% | |
| 4.3981% | |
| 9.9491% | |
| 8.2937% | |
| 17.6592% | |
| -13.2703% | |
| 27.8105% | |
| -3.0418% | |
| 23.2331% | |
| 47.8637% | |
| 54.9195% | |
| -10.4167% | |
| 167.2377% | |
| -4.888% | |
| 25.2551% | |
| -33.4465% | |
| 0% |